J
2003
A double-blind comparison of olanzapine and quetiapine in treatment of acute exacerbations of schizophrenic or schizoaffective disorders
ŠVESTKA, Jaromír, Oldřich SYNEK and Alexandra ŽOURKOVÁ
Basic information
Original name
A double-blind comparison of olanzapine and quetiapine in treatment of acute exacerbations of schizophrenic or schizoaffective disorders
Name in Czech
Dvojitě slepé srovnání účinku Olanzapinu a Quetiapinu při léčbě akutní schizofrenie nebo schizoafektivní poruchy
Authors
ŠVESTKA, Jaromír (203 Czech Republic, guarantor), Oldřich SYNEK (203 Czech Republic) and
Alexandra ŽOURKOVÁ (203 Czech Republic)
Edition
European Neuropsychopharmacology, Amsterodam, Elsevier, 2003, 0924-977X
Other information
Type of outcome
Článek v odborném periodiku
Field of Study
30000 3. Medical and Health Sciences
Country of publisher
Netherlands
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 2.842
RIV identification code
RIV/00216224:14110/03:00008914
Organization unit
Faculty of Medicine
Keywords in English
olanzapine; quetiapine; schizophrenia; efficacy; side effects
Tags
International impact, Reviewed
V originále
Olanzapine and quetiapine proved as highly efficient and well tolerated antipsychotics in the double-blind trial.Olanzapine was significantly more effective than quetipaine.The benefit of quetiapine icluded influencing serum prolactin and triglyceride.
In Czech
Byla provedena studie: Dvojitě slepé srovnání účinku Olanzapinu a Quetiapinu při léčbě akutní schizofrenie nebo schizoafektivní poruchy
Displayed: 5/11/2024 06:53